This adipokine can inhibit cell proliferation and promote apoptosis [19, 20], which could protect against breast carcinogenesis and progression; however, it has been suggested that ADIPOQ participates in BC growth through the presence of the estrogen receptor α (ERα) in the tumour [16, 21]. This evidence concerns the gene ADIPOQ and neoplasm.